FDA Approved: AKYNZEO — Original Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

FDA approved the original application for AKYNZEO, a fixed-dose combination of fosnetupitant and palonosetron, to prevent chemotherapy-induced nausea and vomiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)

Snippet

ORIG AP for AKYNZEO (FOSNETUPITANT AND PALONOSETRON)